Table 4.

Univariate analysis for All-cause death and MACE

	All-cause death			MACE
	HR	95% CI	P	HR	95% CI	P
Low STB	1.89	0.85-4.22	0.116	1.75	1.22-2.51	0.003
Elderly	2.46	1.11-5.41	0.026	1.05	0.73-1.50	0.809
Gender (male)	0.61	0.28-1.31	0.203	1.51	1.01-2.26	0.045
Hypertension	1.67	0.74-3.75	0.214	1.13	0.79-1.61	0.52
Diabetes mellitus	2.39	1.08-5.27	0.031	1.24	0.82-1.87	0.30
Dyslipidemia	1.09	0.51-2.38	0.812	1.13	0.79-1.61	0.51
GFR (ml·min-1·1.73 m-2)	0.94	0.87-1.86	0.732	0.96	0.83-2.11	0.87
Total cholesterol	0.91	0.62-1.33	0.626	1.09	0.94-1.28	0.24
HDL-C	0.61	0.16-2.37	0.478	0.91	0.52-1.59	0.73
LDL-C	0.99	0.66-1.50	0.99	1.12	0.94-1.32	0.21
Triglyceride	0.82	0.54-1.27	0.82	1.11	1.02-1.21	0.02
Peripheral vascular disease	9.46	1.27-70.38	0.028	1.98	0.28-14.2	0.29
Prior myocardial infarction	1.28	0.44-3.72	0.648	0.92	0.53-1.59	0.76
Cerebral vascular disease	1.26	0.82-3.38	0.62	0.89	0.37-2.19	0.81
History of revascularization	1.18	0.76-4.82	0.32	1.83	1.07-3.14	0.028
Anemia	1.78	0.79-3.99	0.163	0.98	0.64-1.49	0.91
Multivessel disease	3.29	1.52-7.09	0.002	1.56	1.07-2.28	0.22
LVEF ≤40	2.12	1.45-4.82	0.008	0.89	0.45-1.79	0.75
Chronic total occlusions	3.29	1.32-8.21	0.011	2.04	1.25-3.32	0.004
Left main coronary lesion	3.64	0.86-15.4	0.079	2.84	1.32-6.09	0.007
Number of treated vessels	1.64	0.97-2.77	0.063	1.24	0.96-1.59	0.104
Number of stents per patient	1.35	1.05-1.74	0.027	1.17	1.03-1.33	0.013
Length of stents implanted (sum of length per patient)	1.01	1.00-1.02	0.01	1.01	1.00-1.01	0.015

STB: serum total bilirubin; LDL-C: Low density lipoprotein cholesterol; HDL-C: High density lipoprotein cholesterol; LVEF: left ventricle ejection fraction.